Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

DANAHER CORPORATION

(DHR)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
07/23/2021 07/26/2021 07/27/2021 07/28/2021 07/29/2021 Date
291.27(c) 290.18(c) 290.6(c) 292.88(c) 297.63(c) Last
2 076 219 2 018 124 1 731 994 2 148 363 1 776 822 Volume
+0.80% -0.37% +0.14% +0.78% +1.62% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 28 653 M - -
Net income 2021 6 160 M - -
Net Debt 2021 13 539 M - -
P/E ratio 2021 36,0x
Yield 2021 0,29%
Sales 2022 30 031 M - -
Net income 2022 6 027 M - -
Net Debt 2022 9 079 M - -
P/E ratio 2022 37,0x
Yield 2022 0,31%
Capitalization 212 B 212 B -
EV / Sales 2021 7,89x
EV / Sales 2022 7,38x
Nbr of Employees 68 000
Free-Float 74,2%
More Financials
Company
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through three segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies... 
More about the company
Ratings of Danaher Corporation
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B+
More Ratings
All news about DANAHER CORPORATION
07/28INSIDER TRENDS : Insider at Danaher Corp Acquires Stock Via Option/Derivative Se..
MT
07/27DANAHER : Unit, Cytiva Team Up to Invest $1.5 Billion to Expand Manufacturing Ca..
MT
07/27CYTIVA : and Pall Corporation investing 1.5 billion USD over two years to meet g..
PR
07/26DANAHER : Four Sustainability Kaizens Add Up to Savings
PU
07/26DANAHER CORP /DE/ : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
07/26DANAHER : Beckman Coulter to Distribute BNP Cardiac Assay to Customers
PR
07/23DANAHER : Goldman Sachs Adjusts Danaher's Price Target to $320 from $280, Keeps ..
MT
07/23DANAHER : JPMorgan Adjusts Danaher's Price Target to $310 from $280, Keeps Overw..
MT
07/23DANAHER : Wells Fargo Adjusts Danaher's Price Target to $320 from $290, Keeps Ov..
MT
07/23DANAHER : Baird Adjusts Danaher's Price Target to $305 From $270, Reiterates Out..
MT
07/23DANAHER : RBC Boosts Price Target on Danaher to $304 From $285, Reiterates Secto..
MT
07/23DANAHER : UBS Adjusts Danaher's Price Target to $322 From $302, Citing 2021 Guid..
MT
07/23DANAHER : Barclays Adjusts Danaher's Price Target to $335 From $310, Maintains O..
MT
07/22Danaher Corporation Provides Revenue Guidance for the Third Quarter and Full ..
CI
07/22Danaher Raises 2021 Adjusted Core-Revenue Outlook
DJ
More news
News in other languages on DANAHER CORPORATION
04/22STOCK MARKET PARIS : Biden, Lagarde et un déluge de publications
04/22EN DIRECT DES MARCHESá : Renault, Hermès, Orange, Pernod Ricard, Ipsen, Nestlé, ..
03/10LOCATION D'AVIONS : GE confirme une fusion à 30 mds de dollars entre Gecas et Ae..
03/09AerCap discute avec GE d'un rapprochement avec sa filiale de location d'avion..
03/08General Electric proche d'un accord sur le rapprochement de Gecas et Aercap -..
More news
Analyst Recommendations on DANAHER CORPORATION
More recommendations
Stock Trading Strategies
DANAHER CORPORATION - 06/22
The beginning of the move
BUY
More Stock Trading Analysis
Chart DANAHER CORPORATION
Duration : Period :
Danaher Corporation Technical Analysis Chart | DHR | US2358511028 | MarketScreener
Technical analysis trends DANAHER CORPORATION
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 23
Last Close Price 297,63 $
Average target price 313,63 $
Spread / Average Target 5,38%
EPS Revisions
Managers and Directors
Rainer M. Blair President, Chief Executive Officer & Director
Matthew R. McGrew Chief Financial Officer & Executive Vice President
Steven M. Rales Chairman
Jose Carlos GutiÚrrez Ramos Chief Science Officer & Senior Vice President
Brian W. Ellis Senior Vice President & General Counsel
Sector and Competitors